AAAAAA

   
Results: 1-25 | 26-50 | 51-75 | 76-100 | >>
Results: 76-100/101
PHYSICIAN-DETERMINED PATIENT RISK OF TOXIC EFFECTS - IMPACT ON ENROLLMENT AND DECISION-MAKING IN PHASE-I CANCER TRIALS
Authors: MICK R LANE N DAUGHERTY C RATAIN MJ
Citation: R. Mick et al., PHYSICIAN-DETERMINED PATIENT RISK OF TOXIC EFFECTS - IMPACT ON ENROLLMENT AND DECISION-MAKING IN PHASE-I CANCER TRIALS, Journal of the National Cancer Institute, 86(22), 1994, pp. 1685-1693
PHASE-I TRIAL OF A GENETICALLY-ENGINEERED INTERLEUKIN-2 FUSION TOXIN (DAB(486)IL-2) AS A 6-HOUR INTRAVENOUS-INFUSION IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES
Authors: PLATANIAS LC RATAIN MJ OBRIEN S LARSON RA VARDIMAN JW SHAW JP WILLIAMS SF BARON JM PARKER K WOODWORTH TG
Citation: Lc. Platanias et al., PHASE-I TRIAL OF A GENETICALLY-ENGINEERED INTERLEUKIN-2 FUSION TOXIN (DAB(486)IL-2) AS A 6-HOUR INTRAVENOUS-INFUSION IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES, Leukemia & lymphoma, 14(3-4), 1994, pp. 257-262
INTERFERON TREATMENT FOR HAIRY-CELL LEUKEMIA - AN UPDATE ON A COHORT OF 69 PATIENTS TREATED FROM 1983 TO 1986
Authors: SPIELBERGER RT MICK R RATAIN MJ GOLOMB HM
Citation: Rt. Spielberger et al., INTERFERON TREATMENT FOR HAIRY-CELL LEUKEMIA - AN UPDATE ON A COHORT OF 69 PATIENTS TREATED FROM 1983 TO 1986, Leukemia & lymphoma, 14, 1994, pp. 89-93
PHASE-I TRIAL OF THIOTEPA, GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR AND PREDNISONE OR PENTOXIFYLLINE IN PATIENTS WITH REFRACTORY SOLID TUMORS
Authors: DEVINE SM RATAIN MJ JANISCH L RICHARDS JM WILLIAMS SF SCHILSKY RL VOGELZANG NJ SKOSEY C
Citation: Sm. Devine et al., PHASE-I TRIAL OF THIOTEPA, GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR AND PREDNISONE OR PENTOXIFYLLINE IN PATIENTS WITH REFRACTORY SOLID TUMORS, Oncology Reports, 1(1), 1994, pp. 213-216
PHARMACODYNAMICS AND LONG-TERM TOXICITY OF ETOPOSIDE
Authors: KOBAYASHI K RATAIN MJ
Citation: K. Kobayashi et Mj. Ratain, PHARMACODYNAMICS AND LONG-TERM TOXICITY OF ETOPOSIDE, Cancer chemotherapy and pharmacology, 34, 1994, pp. 190000064-190000068
SEQUENTIAL THERAPY WITH DACARBAZINE AND CARMUSTINE - A PHASE-I STUDY
Authors: MITCHELL RB DOLAN ME JANISCH L VOGELZANG NJ RATAIN MJ SCHILSKY RL
Citation: Rb. Mitchell et al., SEQUENTIAL THERAPY WITH DACARBAZINE AND CARMUSTINE - A PHASE-I STUDY, Cancer chemotherapy and pharmacology, 34(6), 1994, pp. 509-514
UNTITLED
Authors: MICK R RATAIN MJ
Citation: R. Mick et Mj. Ratain, UNTITLED, Cancer chemotherapy and pharmacology, 34(6), 1994, pp. 535-536
EVALUATION OF NEUROPATHY IN PATIENTS ON SURAMIN TREATMENT
Authors: ARORA R DHAND UK KOBAYASHI K VOKES EE MARTIN B JANISCH L RATAIN MJ SOLIVEN B
Citation: R. Arora et al., EVALUATION OF NEUROPATHY IN PATIENTS ON SURAMIN TREATMENT, Neurology, 44(4), 1994, pp. 10000306-10000306
PHASE-I TRIALS - EXPECTATIONS OF CANCER-PATIENTS AND THEIR ONCOLOGISTS
Authors: DAUGHERTY CK RATAIN MJ GROCHOWSKI E KODISH E MICK R STOCKING C SIEGLER M
Citation: Ck. Daugherty et al., PHASE-I TRIALS - EXPECTATIONS OF CANCER-PATIENTS AND THEIR ONCOLOGISTS, Clinical research, 42(3), 1994, pp. 10000370-10000370
RELATIONSHIP OF CPT-11 INDUCED DIARRHEA TO GLUCURONIDATION OF ITS METABOLITE SN-38
Authors: GUPTA E LESTINGI TM MICK R RAMIREZ J VOKES EE RATAIN MJ
Citation: E. Gupta et al., RELATIONSHIP OF CPT-11 INDUCED DIARRHEA TO GLUCURONIDATION OF ITS METABOLITE SN-38, Clinical research, 42(3), 1994, pp. 10000394-10000394
BOOTSTRAP VALIDATION OF PHARMACODYNAMIC MODELS DEFINED VIA STEPWISE LINEAR-REGRESSION
Authors: MICK R RATAIN MJ
Citation: R. Mick et Mj. Ratain, BOOTSTRAP VALIDATION OF PHARMACODYNAMIC MODELS DEFINED VIA STEPWISE LINEAR-REGRESSION, Clinical pharmacology and therapeutics, 56(2), 1994, pp. 217-222
A POPULATION-MODEL FOR THE LEUKOPENIC EFFECT OF ETOPOSIDE
Authors: KARLSSON MO PORT RE RATAIN MJ SHEINER LB
Citation: Mo. Karlsson et al., A POPULATION-MODEL FOR THE LEUKOPENIC EFFECT OF ETOPOSIDE, Clinical pharmacology and therapeutics, 55(2), 1994, pp. 152-152
A PHASE-I STUDY OF SURAMIN (SUR) IN PATIENTS WITH ADVANCED CANCER (CA)
Authors: KOBAYASHI K VOKES EE JANISCH L PARKS C VOGELZANG NJ RATAIN MJ
Citation: K. Kobayashi et al., A PHASE-I STUDY OF SURAMIN (SUR) IN PATIENTS WITH ADVANCED CANCER (CA), Clinical pharmacology and therapeutics, 55(2), 1994, pp. 190-190
METABOLIC-FATE OF IRINOTECAN IN HUMANS - CORRELATION OF GLUCURONIDATION WITH DIARRHEA
Authors: GUPTA F LESTINGI TM MICK R RAMIREZ J VOKES EE RATAIN MJ
Citation: F. Gupta et al., METABOLIC-FATE OF IRINOTECAN IN HUMANS - CORRELATION OF GLUCURONIDATION WITH DIARRHEA, Cancer research, 54(14), 1994, pp. 3723-3725
PHASE-I AND PHARMACOKINETIC STUDY OF A NEW ANTINEOPLASTIC AGENT - PYRAZINE DIAZOHYDROXIDE (NSC-361456)
Authors: VOGELZANG NJ MICK R JANISCH L BEREZIN F SCHILSKY RL RATAIN MJ
Citation: Nj. Vogelzang et al., PHASE-I AND PHARMACOKINETIC STUDY OF A NEW ANTINEOPLASTIC AGENT - PYRAZINE DIAZOHYDROXIDE (NSC-361456), Cancer research, 54(1), 1994, pp. 114-119
PROGNOSTIC FACTORS FOR SURVIVAL IN PATIENTS TREATED IN PHASE-I CLINICAL-TRIALS
Authors: JANISCH L MICK R SCHILSKY RL VOGELZANG NJ OBRIEN S KUT M RATAIN MJ
Citation: L. Janisch et al., PROGNOSTIC FACTORS FOR SURVIVAL IN PATIENTS TREATED IN PHASE-I CLINICAL-TRIALS, Cancer, 74(7), 1994, pp. 1965-1973
A PHASE-I STUDY OF INTERMITTENT INFUSION CLADRIBINE IN PATIENTS WITH SOLID TUMORS
Authors: KOBAYASHI K VOGELZANG NJ OBRIEN SM SCHILSKY RL VOKES EE RATAIN MJ
Citation: K. Kobayashi et al., A PHASE-I STUDY OF INTERMITTENT INFUSION CLADRIBINE IN PATIENTS WITH SOLID TUMORS, Cancer, 74(1), 1994, pp. 168-173
STATISTICAL AND ETHICAL ISSUES IN THE DESIGN AND CONDUCT OF PHASE-I AND PHASE-II CLINICAL-TRIALS OF NEW ANTICANCER AGENTS
Authors: RATAIN MJ MICK R SCHILSKY RL SIEGLER M
Citation: Mj. Ratain et al., STATISTICAL AND ETHICAL ISSUES IN THE DESIGN AND CONDUCT OF PHASE-I AND PHASE-II CLINICAL-TRIALS OF NEW ANTICANCER AGENTS, Journal of the National Cancer Institute, 85(20), 1993, pp. 1637-1643
PHASE-I TRIAL OF GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR PLUS HIGH-DOSE CYCLOPHOSPHAMIDE GIVEN EVERY 2 WEEKS - A CANCER AND LEUKEMIA GROUP-B STUDY
Authors: LICHTMAN SM RATAIN MJ VANECHO DA ROSNER G EGORIN MJ BUDMAN DR VOGELZANG NJ NORTON L SCHILSKY RL
Citation: Sm. Lichtman et al., PHASE-I TRIAL OF GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR PLUS HIGH-DOSE CYCLOPHOSPHAMIDE GIVEN EVERY 2 WEEKS - A CANCER AND LEUKEMIA GROUP-B STUDY, Journal of the National Cancer Institute, 85(16), 1993, pp. 1319-1326
5-FLUOROURACIL, HYDROXYUREA AND ESCALATING DOSES OF IODODEOXYURIDINE WITH CONCOMITANT RADIOTHERAPY FOR MALIGNANT GLIOMAS - A CLINICAL AND PHARMACOLOGICAL ANALYSIS
Authors: VOKES EE DOLAN ME KRISHNASAMY S MICK R RATAIN MJ BEREZIN F BRACHMAN D WHITMAN G SCHILSKY RL CHARETTE J WEICHSELBAUM RR DOHRMANN GJ HEKMATPANAH J
Citation: Ee. Vokes et al., 5-FLUOROURACIL, HYDROXYUREA AND ESCALATING DOSES OF IODODEOXYURIDINE WITH CONCOMITANT RADIOTHERAPY FOR MALIGNANT GLIOMAS - A CLINICAL AND PHARMACOLOGICAL ANALYSIS, Annals of oncology, 4(7), 1993, pp. 591-595
STATISTICAL APPROACHES TO PHARMACODYNAMIC MODELING - MOTIVATIONS, METHODS, AND MISPERCEPTIONS
Authors: MICK R RATAIN MJ
Citation: R. Mick et Mj. Ratain, STATISTICAL APPROACHES TO PHARMACODYNAMIC MODELING - MOTIVATIONS, METHODS, AND MISPERCEPTIONS, Cancer chemotherapy and pharmacology, 33(1), 1993, pp. 1-9
5-DAY INFUSIONAL FLUORODEOXYURIDINE WITH ORAL LEUCOVORIN AND ESCALATING DOSES OF INTERFERON-ALPHA-2B - A PHASE-I STUDY
Authors: VOKES EE OBRIEN SM VOGELZANG NJ SCHILSKY RL RATAIN MJ
Citation: Ee. Vokes et al., 5-DAY INFUSIONAL FLUORODEOXYURIDINE WITH ORAL LEUCOVORIN AND ESCALATING DOSES OF INTERFERON-ALPHA-2B - A PHASE-I STUDY, Cancer chemotherapy and pharmacology, 32(5), 1993, pp. 347-352
PHARMACODYNAMIC-PHARMACOKINETIC RELATIONSHIPS AND THERAPEUTIC DRUG-MONITORING
Authors: KOBAYASHI K JODRELL DI RATAIN MJ
Citation: K. Kobayashi et al., PHARMACODYNAMIC-PHARMACOKINETIC RELATIONSHIPS AND THERAPEUTIC DRUG-MONITORING, Cancer surveys, 17, 1993, pp. 51-78
MODULATION OF VINBLASTINE RESISTANCE WITH CYCLOSPORINE - A PHASE-I STUDY
Authors: SAMUELS BL MICK R VOGELZANG NJ WILLIAMS SF SCHILSKY RL SAFA AR OBRIEN SM RATAIN MJ
Citation: Bl. Samuels et al., MODULATION OF VINBLASTINE RESISTANCE WITH CYCLOSPORINE - A PHASE-I STUDY, Clinical pharmacology and therapeutics, 54(4), 1993, pp. 421-429
PHASE-I STUDY OF AMONAFIDE DOSING BASED ON ACETYLATOR PHENOTYPE
Authors: RATAIN MJ MICK R BEREZIN F JANISCH L SCHILSKY RL VOGELZANG NJ LANE LB
Citation: Mj. Ratain et al., PHASE-I STUDY OF AMONAFIDE DOSING BASED ON ACETYLATOR PHENOTYPE, Cancer research, 53(10), 1993, pp. 2304-2308
Risultati: 1-25 | 26-50 | 51-75 | 76-100 | >>